Friday, September 25, 2009

Sign up for the FierceBiotech newsletter, my man

FierceBiotech is the biotech industry's daily monitor, with a special focus on clinical trials, biotech & pharma deals, FDA decisions, and key regulatory issues
Posted by at

2 comments:

  1. AnonymousSeptember 26, 2009 at 9:42 PM

    what is the target price for this for short term before the reverse split?

    ReplyDelete
  2. AnonymousSeptember 27, 2009 at 4:15 PM

    The newsletter?

    ReplyDelete

Subscribe to: Post Comments (Atom)